Intelligent Bio Solutions (INBS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.50, +4.17% vs the prior close of $1.44.
- Volume 23.53K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
INBS jumps 4.2% to $1.50. Closed at $1.50, +4.17% vs the prior close of $1.44. Day range $1.40–$1.51, opened at $1.46.
INBS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INBS jumps 4.2% to $1.50
- Closed at $1.50, +4.17% vs the prior close of $1.44. Day range $1.40–$1.51, opened at $1.46.
- Volume was 23.53K shares, 0.1x its 50-day average of 177.32K — lighter than usual.
- Price is -27.5% vs its 50-day average ($2.07) and -59.9% vs its 200-day average ($3.74).
- 52-week range $1.35–$24.90; today's close sits at 1% of that range, 94.0% below the 52-week high.
Oct 15, 2026 — INBS dips 0.7% to $1.44, a 52-week low, 6 down days in a row
- Closed at $1.44, -0.69% vs the prior close of $1.45. Day range $1.37–$1.50, opened at $1.41.
- Volume was 50.60K shares, 0.3x its 50-day average of 177.01K — lighter than usual.
- Price is -30.7% vs its 50-day average ($2.08) and -61.7% vs its 200-day average ($3.76).
- 52-week range $1.35–$24.90; today's close sits at 0% of that range, 94.2% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — INBS dips 2.0% to $1.45, a 52-week low, 5 down days in a row
- Closed at $1.45, -2.03% vs the prior close of $1.48. Day range $1.35–$1.46, opened at $1.36.
- Volume was 95.40K shares, 0.5x its 50-day average of 175.79K — lighter than usual.
- Price is -30.5% vs its 50-day average ($2.09) and -61.5% vs its 200-day average ($3.77).
- 52-week range $1.35–$24.90; today's close sits at 0% of that range, 94.2% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — INBS dips 2.0% to $1.48, a 52-week low, 4 down days in a row
- Closed at $1.48, -1.99% vs the prior close of $1.51. Day range $1.45–$1.51, opened at $1.50.
- Volume was 213.90K shares, 1.2x its 50-day average of 172.22K.
- Price is -29.3% vs its 50-day average ($2.09) and -60.9% vs its 200-day average ($3.79).
- 52-week range $1.45–$24.90; today's close sits at 0% of that range, 94.1% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — INBS dips 1.3% to $1.51, a 52-week low, 3 down days in a row
- Closed at $1.51, -1.31% vs the prior close of $1.53. Day range $1.50–$1.56, opened at $1.54.
- Volume was 20.10K shares, 0.1x its 50-day average of 175.11K — lighter than usual.
- Price is -28.1% vs its 50-day average ($2.10) and -60.3% vs its 200-day average ($3.81).
- 52-week range $1.50–$24.90; today's close sits at 0% of that range, 93.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — INBS dips 2.5% to $1.53, a 52-week low
- Closed at $1.53, -2.55% vs the prior close of $1.57. Day range $1.52–$1.60, opened at $1.60.
- Volume was 15.00K shares, 0.1x its 50-day average of 175.17K — lighter than usual.
- Price is -27.3% vs its 50-day average ($2.11) and -60.0% vs its 200-day average ($3.82).
- 52-week range $1.52–$24.90; today's close sits at 0% of that range, 93.9% below the 52-week high.
Oct 8, 2026 — INBS dips 1.3% to $1.57, a 1-month low
- Closed at $1.57, -1.26% vs the prior close of $1.59. Day range $1.55–$1.64, opened at $1.59.
- Volume was 17.50K shares, 0.1x its 50-day average of 175.41K — lighter than usual.
- Price is -25.5% vs its 50-day average ($2.11) and -59.2% vs its 200-day average ($3.85).
- 52-week range $1.52–$24.90; today's close sits at 0% of that range, 93.7% below the 52-week high.
Oct 7, 2026 — INBS rises 0.6% to $1.59
- Closed at $1.59, +0.63% vs the prior close of $1.58. Day range $1.54–$1.61, opened at $1.57.
- Volume was 20.80K shares, 0.1x its 50-day average of 176.10K — lighter than usual.
- Price is -24.5% vs its 50-day average ($2.11) and -58.9% vs its 200-day average ($3.87).
- 52-week range $1.52–$24.90; today's close sits at 0% of that range, 93.6% below the 52-week high.
Oct 6, 2026 — INBS slides 5.4% to $1.58, a 1-month low
- Closed at $1.58, -5.39% vs the prior close of $1.67. Day range $1.57–$1.81, opened at $1.68.
- Volume was 97.10K shares, 0.6x its 50-day average of 174.71K — lighter than usual.
- Price is -25.0% vs its 50-day average ($2.11) and -59.4% vs its 200-day average ($3.90).
- 52-week range $1.52–$24.90; today's close sits at 0% of that range, 93.7% below the 52-week high.
Oct 5, 2026 — INBS rises 0.6% to $1.67
- Closed at $1.67, +0.60% vs the prior close of $1.66. Day range $1.65–$1.70, opened at $1.67.
- Volume was 77.90K shares, 0.4x its 50-day average of 174.39K — lighter than usual.
- Price is -20.8% vs its 50-day average ($2.11) and -57.4% vs its 200-day average ($3.92).
- 52-week range $1.52–$24.90; today's close sits at 1% of that range, 93.3% below the 52-week high.
Oct 2, 2026 — INBS ends flat (+0.0%) to $1.66
- Closed at $1.66, +0.00% vs the prior close of $1.66. Day range $1.64–$1.75, opened at $1.70.
- Volume was 43.10K shares, 0.2x its 50-day average of 174.70K — lighter than usual.
- Price is -21.3% vs its 50-day average ($2.11) and -57.8% vs its 200-day average ($3.94).
- 52-week range $1.52–$24.90; today's close sits at 1% of that range, 93.3% below the 52-week high.
INBS latest news & SEC filings
Every SEC filing by or about INBS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 23, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 15, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 19, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $4.22M (prior year $3.05M) (+38.1% vs Jun 30, 2025)
- Net income: -$12.43M (prior year -$10.57M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$8.44 (prior year -$20.04) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade INBS
- Last results release: Aug 19, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Feb 12, 2026, Feb 5, 2026. Based on that rhythm, the next report is likely around Nov 18, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.06% (largest 7.2%).
- Liquidity: about 54.07K shares (≈$81.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.50 vs a range of $1.35–$24.90 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Dec 16, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 8-K Sep 11, 2026; 8-K Sep 9, 2026.
- Share count: 3.03M shares outstanding (Aug 18, 2026), -66.3% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
INBS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.46 | 1.51 | 1.40 | 1.50 | 23.53K |
| Oct 15, 2026 | 1.41 | 1.50 | 1.37 | 1.44 | 50.60K |
| Oct 14, 2026 | 1.36 | 1.46 | 1.35 | 1.45 | 95.40K |
| Oct 13, 2026 | 1.50 | 1.51 | 1.45 | 1.48 | 213.90K |
| Oct 12, 2026 | 1.54 | 1.56 | 1.50 | 1.51 | 20.10K |
| Oct 9, 2026 | 1.60 | 1.60 | 1.52 | 1.53 | 15.00K |
| Oct 8, 2026 | 1.59 | 1.64 | 1.55 | 1.57 | 17.50K |
| Oct 7, 2026 | 1.57 | 1.61 | 1.54 | 1.59 | 20.80K |
| Oct 6, 2026 | 1.68 | 1.81 | 1.57 | 1.58 | 97.10K |
| Oct 5, 2026 | 1.67 | 1.70 | 1.65 | 1.67 | 77.90K |
| Oct 2, 2026 | 1.70 | 1.75 | 1.64 | 1.66 | 43.10K |
| Oct 1, 2026 | 1.72 | 1.75 | 1.65 | 1.66 | 33.90K |
| Sep 30, 2026 | 1.68 | 1.92 | 1.65 | 1.67 | 40.30K |
| Sep 29, 2026 | 1.72 | 1.72 | 1.60 | 1.63 | 62.00K |
| Sep 28, 2026 | 1.64 | 1.73 | 1.64 | 1.65 | 24.50K |
| Sep 25, 2026 | 1.74 | 1.84 | 1.70 | 1.70 | 25.70K |
| Sep 24, 2026 | 1.79 | 1.86 | 1.65 | 1.71 | 94.00K |
| Sep 23, 2026 | 1.80 | 1.90 | 1.77 | 1.77 | 27.50K |
| Sep 22, 2026 | 1.83 | 1.94 | 1.77 | 1.80 | 50.20K |
| Sep 21, 2026 | 1.95 | 1.96 | 1.79 | 1.81 | 48.40K |
About Intelligent Bio Solutions
Intelligent Bio Solutions (INBS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1725430.
INBS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven Constantine Boyages | Director | Mar 20, 2026 |
| Nicola Marion Fraser | Director | Mar 20, 2026 |
| Jonathan Scott Hurd | Director | Mar 20, 2026 |
| Jason Isenberg | Director | Mar 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Spiro Kevin Sakiris | Chief Financial Officer | Mar 20, 2026 |
| Harry Simeonidis | Chief Executive Officer | Mar 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
INBS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $4.22M | $-12.43M | -8.44 | $-11.93M |
| Jun 30, 2025 | $3.05M | $-10.57M | -20.04 | $-9.68M |
| Jun 30, 2024 | $3.11M | $-10.16M | -6.38 | $-9.57M |
| Jun 30, 2023 | $1.26M | $-10.63M | -127.00 | $-7.38M |
| Jun 30, 2022 | $437.15K | $-8.31M | -11.33 | $-3.36M |
Latest balance sheet: total assets $11.94M, total liabilities $6.65M, cash $3.99M (as of Jun 30, 2026).
INBS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 19, 2026 | 8-K Item 2.02 (results) | $2.67 |
| May 14, 2026 | 8-K Item 2.02 (results) | $4.11 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $4.90 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $6.32 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $7.93 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $7.71 |
| Aug 15, 2025 | 8-K Item 2.02 (results) | $14.70 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $15.50 |
| May 13, 2025 | 8-K Item 2.02 (results) | $13.60 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $23.70 |
| Feb 10, 2025 | 8-K Item 2.02 (results) | $20.90 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $19.50 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INBS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.